Interested in learning more about implementing Geistlich biomaterials in your practice? Connect with the Geistlich team to explore product evaluations, receive clinical guidance, and access support to help integrate these regenerative solutions into your patient care.

Terms and Conditions: Valid January 1–December 31, 2026. Each trial is limited to a total of 4 units of biomaterial, of which one unit can be GEM 21S. Only valid for new customers or a new product category to existing customers. Excludes Yxoss, RPM, Meisinger, Meta, and McBio products. Not applicable for Government, and Military Accounts. Submission and feedback form must be submitted for qualification. The user agrees to have the Geistlich Regenerative Specialist observe the surgery and post-surgery survey.